PRCT
Procept Biorobotics Corp Health Care Surgical & Medical Instruments & Apparatus Russell 3000
$19.20Close
$1.1BMarket cap
$16.69 – $36.1052-week range
Nov 4, 2026Next report · after the close
Highlights
Cautions
- Not in an uptrend 0 of 8 trend conditions
- Lagging the market RS 16 · weaker than 84% of stocks over 12 months
- Far from its high 47% below its 52-week high
- Results soon Nov 4, 2026, in 3 days
Price
Filing Results Screen pick 52-week high and low Adjusted prices
Key figures
Off 12-month high
47%
1wk
down 3.8%
price change
1mo
up 5.4%
price change
12-month return
down 44%
market up 11% ·
its own down 57%
F-score
4 / 9
Weak
Altman Z
3.63
Low risk
P/E
—
price / earnings
PEG
—
P/E / EPS growth
P/B
3.0×
price / book
Earnings yield
down 12.3%
EBIT / enterprise value
Cheaper than
25%
of the market · expensive
Revenue growth
up 37%
year on year
EPS growth
—
latest quarter
Sales growth
up 19%
latest quarter · -1 pts
ROE
0%
return on equity
Free cash margin
down 19%
-$58.3M FCF
D/E
0.14
long-term debt / equity
Net debt / EBITDA
—
Interest cover
—EBIT / interest
Piotroski tests
- not yet profitable on its assets
- operating cash flow is negative
- profits not fully backed by cash
- short-term liquidity weakened
- issued more shares
- profitability improving
- reduced long-term debt
- gross margin widened
- assets working harder
Repair signals
- Gross margin 61.1% → 63.7%
Trade setup
ATR%
5.3%
$1.01 a day · 2×ATR $17.17
RS
16 / 99
vs the universe
Trend
0 / 8
trend template
Relative volume
0.7×
vs 50-day average
Up/down volume
0.90
50 sessions
Implied move
—
no option chain · report Nov 4, 2026
Trend template · 0 of 8
Screen verdict
Did not qualify for any screen.
Warning signs
- Shareholders diluted The share count rose 2.9% over the year, from 55m to 56m shares. Each existing share owns a smaller fraction of the company than it did a year ago.
Last reported
Aug 4, 2026
Results reaction
Aug 4, 2026+4% vs market2 sessions after results
Financials
- Gross 64%
- Net -0%
- Free cash -19%
- Cash
- Long-term debt
| FY2020Dec 31, 2020 | FY2021Dec 31, 2021 | FY2022Dec 31, 2022 | FY2023Dec 31, 2023 | FY2024Dec 31, 2024 | FY2025Dec 31, 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $7.7M | $34.5M | $75.0M | $136.2M | $224.5M | $308.1M |
| Gross margin | -16% | 46% | 49% | 52% | 61% | 64% |
| Operating income | -$47.8M | -$54.2M | -$80.7M | -$109.2M | -$96.6M | -$103.9M |
| Net income | -$53.0M | -$59,853 | -$87,154 | -$105,897 | -$91,413 | -$95,572 |
| Net margin | -687% | -0% | -0% | -0% | -0% | -0% |
| Earnings per share | -$14.47 | -$0.00 | -$0.00 | -$0.00 | -$0.00 | -$0.00 |
| Free cash flow | -$48.6M | -$57.9M | -$83.0M | -$133.2M | -$103.6M | -$58.3M |
| Free cash margin | -629% | -168% | -111% | -98% | -46% | -19% |
| Cash | $100.1M | $304.3M | $221.9M | $257.2M | $333.7M | $286.5M |
| Long-term debt | $44.4M | $50.0M | $51.2M | $51.3M | $51.5M | $51.6M |
| Shareholders' equity | -$182.9M | $267.1M | $197.1M | $280.8M | $402.2M | $365.9M |
| Shares outstanding | 4.71m | 43.68m | 44.83m | 50.77m | 54.72m | 56.32m |
Filings
| Filed | Report | Period to | Lag |
|---|---|---|---|
| Aug 5, 2026 | Quarterly ↗ | Jun 30, 2026 | 36d |
| Apr 30, 2026 | Quarterly ↗ | Mar 31, 2026 | 30d |
| Feb 26, 2026 | Annual ↗ | Dec 31, 2025 | 57d |
| Nov 5, 2025 | Quarterly ↗ | Sep 30, 2025 | 36d |
| Aug 7, 2025 | Quarterly ↗ | Jun 30, 2025 | 38d |
| May 2, 2025 | Quarterly ↗ | Mar 31, 2025 | 32d |
| Feb 27, 2025 | Annual ↗ | Dec 31, 2024 | 58d |
| Oct 28, 2024 | Quarterly ↗ | Sep 30, 2024 | 28d |
| Aug 2, 2024 | Quarterly ↗ | Jun 30, 2024 | 33d |
| May 2, 2024 | Quarterly ↗ | Mar 31, 2024 | 32d |
| Feb 28, 2024 | Annual ↗ | Dec 31, 2023 | 59d |
| Nov 2, 2023 | Quarterly ↗ | Sep 30, 2023 | 33d |
Current reports
| Filed | Disclosed |
|---|---|
| Oct 2, 2026 | Director or officer change ↗ |
| Sep 24, 2026 | Material agreement ↗ |
| Aug 4, 2026 | Results ↗ |
| Jun 10, 2026 | Shareholder vote ↗ |
| Apr 29, 2026 | Results ↗ |
| Mar 6, 2026 | Director or officer change ↗ |
| Feb 26, 2026 | Regulation FD ↗ |
| Feb 25, 2026 | Results ↗ |
| Nov 4, 2025 | Results ↗ |
| Sep 18, 2025 | Director or officer change ↗ |
| Aug 6, 2025 | Results ↗ |
| Jul 25, 2025 | Results · Director or officer change · Regulation FD ↗ |